Advertisement
Home »

#VisualAbstract: High-Dose Recombinant Influenza Vaccine is More Effective than Standard-Dose Vaccine in Adults Aged 50 to 64 Years

Dec 22, 2023

ABOUT THE CONTRIBUTORS

Advertisement
Advertisement